Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing symptoms by 50%.

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...

In connection with Spark’s overhaul, Roche will incur approximately $2.4 billion in goodwill impairment costs. This sum takes ...

Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing ...

The Food and Drug Administration said several lots of six products containing benzoyl peroxide are being recalled, including ...

Some popular acne creams are being recalled because the product may contain elevated levels of benzene, a chemical that causes cancer, the FDA said.

Face care products from several popular brands are being recalled over elevated levels of a potential cancer-causing chemical ...